Biologics Market Size, Share, Growth, Trends Analysis 2024-2030

The Biologics Market report by MarkNtel Advisors – Market Research Company, offers a comprehensive analysis of the current state of the market, including an overview of key players, emerging trends, and future growth prospects. The report is segmented into various sections, each dedicated to different aspects of the market such as market size, geographical shares, competitive landscape, and market dynamics.

How Big is the Biologics Industry?

The Global Biologics Market size reached USD 412 Billion in 2024. Looking forward, it is expected to rise at a CAGR of around 8.25% during the forecast period 2024-2030.

Explore What This Report Can Do for You: Download Free Sample [PDF, Excel, PPT] of the Report: – https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Biologics Market Trend:

Rising Demand for Personalized Medicine Augmenting the Biologics Market Growth – In recent years, there has been a significant increase in the demand for personalized medicines among patients and healthcare professionals across the globe, as they meet the specific needs of an individual. Hence, as biologics can be modified and engineered to fit these requirements, it has been used largely by pharmaceutical companies for the development of personalized medicines, which have been offering more effective & patient-centric treatment options. Thus, the demand for personalized medicine has emerged as a new trend in the Global Biologics Market in recent years.

Moreover, in addition to the development of precision medicines, biologics also play a major role in the identification and development of diagnostic tools such as biomarkers, which allow disease diagnosis. Consequently, with advancements in the usage of biologics for the development of diagnostic methods and precision medicines, it is anticipated to contribute to the market growth in the coming years as well.

Competitor Breakdown: Top Biologics Companies 2024-2030

Bristol-Myers Squibb
Pfizer
Sanofi
Janssen Biotech, Inc.
Bayer AG
Merck & Co.
Amgen Inc.
Abbott GmbH
Novartis
AstraZeneca Plc
GlaxoSmithKline Biologicals
Moderna, Inc.
Ferring Pharmaceuticals Inc.
Aimmune Therapeutics, Inc.
F. Hoffman La Roche

Note: If additional specific information is required beyond the current scope of the report, we will gladly provide it as part of the customization process.

Customization Requests can be Sent Directly to:- https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html

Regional Analysis:

North America, Europe, Asia Pacific, Middle East & Africa, and South America

Share of each region segment in the Market
Potential growth opportunities in the region
The growth rate of the region in the Industry

Breaking Down the Biologics Market Segmentation:

By Therapeutic Application

Oncology- Market Size & Forecast 2019-2030, (USD Million)
Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)
Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)
Diabetes- Market Size & Forecast 2019-2030, (USD Million)
Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)
Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Drug Class

Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)
- Hormones- Market Size & Forecast 2019-2030, (USD Million)
- Cytokines- Market Size & Forecast 2019-2030, (USD Million)
Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)
Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)
Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)
Vaccines- Market Size & Forecast 2019-2030, (USD Million)
Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

Microbes- Market Size & Forecast 2019-2030, (USD Million)
Humans- Market Size & Forecast 2019-2030, (USD Million)
Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million)

Why This Report:

We offer strategic insights and data analytics across 80+ countries, empowering clients to make informed decisions.
Specializing in niche industries and emerging markets, we help clients identify investment opportunities and maximize ROI.
With a global presence and expertise in 15 industry verticals, we deliver comprehensive market research for top multinational firms.
Our skilled team provides in-depth qualitative and quantitative research, ensuring detailed and valuable market insights.
We support clients with Go-to-Market strategies, competitive benchmarking, market sizing, and trend analysis to drive strategic growth.

For Purchase Enquiry or Further Discussion

Connect with our skilled team of analysts and industry experts. We'll work closely with you to understand your business challenges and goals. Together, we'll find unique solutions using simple, effective strategies. [Contact Us Today]

Other Report:

About US

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India